We suggest that the anticholinergic drugs could represent a therapeutic approach that regulates the chromatin remodeling involved in the activation of inflammatory genes, such as TSLP, through IKKα acetylation of histone H3 at Lys14 in the airways of COPD patients. Here, TSLP is linked to chronic obstructive pulmonary disease.